TGF-β1-induced m6A modifications accelerate onset of nuclear cataract in high myopia by modulating the PCP pathway
Year: 2025
Type: article
Abstract: High myopia is an important cause of visual impairment worldwide, characterized by early-onset nuclear cataracts, whose underlying mechanisms remain largely unexplained. Here, we identify conspicuously polarized and compacted lens fiber alignment, along with a simultaneous rise in N6-methyladenosine (m6A) modifications in patients with highly myopic cataracts (HMC), which is confirmed to be induced by elevated transforming growth factor-β1 (TGF-β1) in lens. Mechanistically, methyltransferase METTL3 and m6A reader insulin-like growth factor 2 mRNA binding protein 3 synergistically enhance planar cell polarity (PCP) signaling by affecting mRNA stability of dishevelled 2. This, in turn, alters proliferation, migration, and polarity formation of human lens epithelial cells. Moreover, Mettl3 conditional knockdown in mice leads to disrupted lens fiber arrangement and alleviates TGF-β1-induced increase in lens nuclear density. Collectively, these findings highlight the significance of m6A-modified PCP pathway in regulating postnatal lens fiber organization, which may hold great promise as a therapeutic target for HMC. In highly myopic eyes, early formation of nuclear cataracts with polarized and compacted lens fiber alignment is observed, yet the underlying mechanism is largely unknown. Here, the authors show that TGF-β1-induced m6A modifications contribute to this process by modulating the PCP pathway.
Source: Nature Communications
Institutions: University of Electronic Science and Technology of China, Chinese Academy of Medical Sciences & Peking Union Medical College, Fudan University, Eye & ENT Hospital of Fudan University, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Shanghai Jiao Tong University, Shanghai First People's Hospital, Shanghai Medical College of Fudan University, State Key Laboratory of Medical Neurobiology
Language: English
Topic: RNA modifications and cancer
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $6,990
OpenAlex ID: W4409735692
